Cita APA

Lee, M. Y., Robbins, Y., Sievers, C., Friedman, J., Abdul Sater, H., Clavijo, P. E., . . . Allen, C. (2021). Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells. J Immunother Cancer.

Chicago Style Citation

Lee, Maxwell Y., et al. "Chimeric Antigen Receptor Engineered NK Cellular Immunotherapy Overcomes the Selection of T-cell Escape Variant Cancer Cells." J Immunother Cancer 2021.

Cita MLA

Lee, Maxwell Y., et al. "Chimeric Antigen Receptor Engineered NK Cellular Immunotherapy Overcomes the Selection of T-cell Escape Variant Cancer Cells." J Immunother Cancer 2021.